Other Species / Isoforms
  E2A (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T12-p
QRMAPVGtDKELSDL
0 1
E2A (human) QRMAPVGtDKELSDL T12-p
E2A iso2 (human) QRMAPVGTDKELSDL T12
E2A (mouse) QRMAPVGSDKELSDL S13
E2A iso2 (mouse) QRMAPVGSDKELSDL S13
E2A (rat) QRMAPVGSDKELSDL S13
E2A iso2 (rat) QRMAPVGSDKELSDL S13
K34-ac
PLPVTNGkGRPAsLA
1 0
E2A (human) PLPVTNGkGRPAsLA K34-ac
E2A iso2 (human) PLPVTNGKGRPASLA K34
E2A (mouse) PLPVANGKSRPASLG K35
E2A iso2 (mouse) PLPVANGKSRPASLG K35
E2A (rat) PLPVANGKGRPASLA K35
E2A iso2 (rat) PLPVANGKGRPASLA K35
S39-p
NGkGRPAsLAGAQFG
Upstream
Downstream
1 2
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell adhesion, inhibited
  • cell motility, induced
Kinase, in vitro:
  • PAK5 (human)
Putative in vivo kinases:
  • PAK5 (human)
Treatment
  • HGF
E2A (human) NGkGRPAsLAGAQFG S39-p
E2A iso2 (human) NGKGRPASLAGAQFG S39
E2A (mouse) NGKSRPASLGGtQFA S40
E2A iso2 (mouse) NGKSRPASLGGTQFA S40
E2A (rat) NGKGRPASLAGTQFA S40
E2A iso2 (rat) NGKGRPASLAGTQFA S40
A43
RPAsLAGAQFGGSGL
0 1
E2A (human) RPAsLAGAQFGGSGL A43
E2A iso2 (human) RPASLAGAQFGGSGL A43
E2A (mouse) RPASLGGtQFAGSGL T44-p
E2A iso2 (mouse) RPASLGGTQFAGSGL T44
E2A (rat) RPASLAGTQFAGSGL T44
E2A iso2 (rat) RPASLAGTQFAGSGL T44
K101
LGPGLGGKSGErGAy
0 1
E2A (human) LGPGLGGKSGErGAy K101
E2A iso2 (human) LGPGLGGKSGERGAY K101
E2A (mouse) LGAGLGGKGSERNAY K102
E2A iso2 (mouse) LGAGLGGKGSERNAY K102
E2A (rat) LGAGLGGkGSERNAY K102-ac
E2A iso2 (rat) LGAGLGGKGSERNAY K102
R105-m1
LGGKSGErGAyAsFG
0 2
E2A (human) LGGKSGErGAyAsFG R105-m1
E2A iso2 (human) LGGKSGERGAYASFG R105
E2A (mouse) LGGKGSERNAYATFG R106
E2A iso2 (mouse) LGGKGSERNAYATFG R106
E2A (rat) LGGkGSERNAYATFG R106
E2A iso2 (rat) LGGKGSERNAYATFG R106
Y108-p
KSGErGAyAsFGRDA
0 8
E2A (human) KSGErGAyAsFGRDA Y108-p
E2A iso2 (human) KSGERGAYASFGRDA Y108
E2A (mouse) KGSERNAYATFGRDT Y109
E2A iso2 (mouse) KGSERNAYATFGRDT Y109
E2A (rat) kGSERNAYATFGRDT Y109
E2A iso2 (rat) KGSERNAYATFGRDT Y109
S110-p
GErGAyAsFGRDAGV
0 1
E2A (human) GErGAyAsFGRDAGV S110-p
E2A iso2 (human) GERGAYASFGRDAGV S110
E2A (mouse) SERNAYATFGRDTSV T111
E2A iso2 (mouse) SERNAYATFGRDTSV T111
E2A (rat) SERNAYATFGRDTSV T111
E2A iso2 (rat) SERNAYATFGRDTSV T111
S134-p
SGELALNsPGPLsPs
Upstream
0 3
Treatment
  • nocodazole
E2A (human) SGELALNsPGPLsPs S134-p
E2A iso2 (human) SGELALNSPGPLSPS S134
E2A (mouse) PGELSLSsPGPLsPS S135-p
E2A iso2 (mouse) PGELSLSSPGPLSPS S135
E2A (rat) PGELGLSSPGPLSPS S135
E2A iso2 (rat) PGELGLSSPGPLSPS S135
S139-p
LNsPGPLsPsGMKGT
Upstream
Downstream
2 9
Effects on Biological Processes:
  • cell growth, altered
Kinase, in vitro:
  • CDK2 (human)
  • CDK4 (human)
Treatment
  • nocodazole
E2A (human) LNsPGPLsPsGMKGT S139-p
E2A iso2 (human) LNSPGPLSPSGMKGT S139
E2A (mouse) LSsPGPLsPSGIKSS S140-p
E2A iso2 (mouse) LSSPGPLSPSGIKSS S140
E2A (rat) LSSPGPLSPSGVKSS S140
E2A iso2 (rat) LSSPGPLSPSGVKSS S140
S141-p
sPGPLsPsGMKGTSQ
0 1
E2A (human) sPGPLsPsGMKGTSQ S141-p
E2A iso2 (human) SPGPLSPSGMKGTSQ S141
E2A (mouse) sPGPLsPSGIKSSSQ S142
E2A iso2 (mouse) SPGPLSPSGIKSSSQ S142
E2A (rat) SPGPLSPSGVKSSSQ S142
E2A iso2 (rat) SPGPLSPSGVKSSSQ S142
Y149-p
GMKGTSQyyPSySGs
0 51
E2A (human) GMKGTSQyyPSySGs Y149-p
E2A iso2 (human) GMKGTSQyYPSYSGS Y149-p
E2A (mouse) GIKSSSQYYPSFPSN Y150
E2A iso2 (mouse) GIKSSSQYYPSFPSN Y150
E2A (rat) GVKSSSQYYTSFPSN Y150
E2A iso2 (rat) GVKSSSQYYTSFPSN Y150
Y150-p
MKGTSQyyPSySGsS
0 2
E2A (human) MKGTSQyyPSySGsS Y150-p
E2A iso2 (human) MKGTSQyYPSYSGSS Y150
E2A (mouse) IKSSSQYYPSFPSNP Y151
E2A iso2 (mouse) IKSSSQYYPSFPSNP Y151
E2A (rat) VKSSSQYYTSFPSNP Y151
E2A iso2 (rat) VKSSSQYYTSFPSNP Y151
Y153-p
TSQyyPSySGsSRRR
0 2
E2A (human) TSQyyPSySGsSRRR Y153-p
E2A iso2 (human) TSQyYPSYSGSSRRR Y153
E2A (mouse) SSQYYPSFPSNPRRR F154
E2A iso2 (mouse) SSQYYPSFPSNPRRR F154
E2A (rat) SSQYYTSFPSNPRRR F154
E2A iso2 (rat) SSQYYTSFPSNPRRR F154
S156-p
yyPSySGsSRRRAAD
0 1
E2A (human) yyPSySGsSRRRAAD S156-p
E2A iso2 (human) yYPSYSGSSRRRAAD S156
E2A (mouse) YYPSFPSNPRRRAAD N157
E2A iso2 (mouse) YYPSFPSNPRRRAAD N157
E2A (rat) YYTSFPSNPRRRAAD N157
E2A iso2 (rat) YYTSFPSNPRRRAAD N157
K171-ac
GSLDTQPkKVRKVPP
0 2
E2A (human) GSLDTQPkKVRKVPP K171-ac
E2A iso2 (human) GSLDTQPKKVRKVPP K171
E2A (mouse) GGLDTQPKKVRKVPP K172
E2A iso2 (mouse) GGLDTQPKKVRKVPP K172
E2A (rat) GGLDTQPKKVRKVPP K172
E2A iso2 (rat) GGLDTQPKKVRKVPP K172
S245-p
PMLGGGSsPLPLPPG
Upstream
Downstream
1 0
Effects on Biological Processes:
  • cell growth, altered
Kinase, in vitro:
  • CDK2 (human)
  • CDK4 (human)
E2A (human) PMLGGGSsPLPLPPG S245-p
E2A iso2 (human) PMLGGGSSPLPLPPG S245
E2A (mouse) PMLGDGSSPLPLAPG S246
E2A iso2 (mouse) PMLGDGSSPLPLAPG S246
E2A (rat) PMLGDGSAPLPLAPG A246
E2A iso2 (rat) PMLGDGSAPLPLAPG A246
S338
ALGKALASIYsPDHs
0 1
E2A (human) ALGKALASIYsPDHs S338
E2A iso2 (human) ALGKALASIYSPDHS S338
E2A (mouse) ALGKALAsIysPDHs S336-p
E2A iso2 (mouse) ALGKALASIYSPDHS S336
E2A (rat) ALGKALASIYSPDHS S334
E2A iso2 (rat) ALGKALASIYSPDHS S334
Y340
GKALASIYsPDHssN
0 1
E2A (human) GKALASIYsPDHssN Y340
E2A iso2 (human) GKALASIYSPDHSSN Y340
E2A (mouse) GKALAsIysPDHssN Y338-p
E2A iso2 (mouse) GKALASIYSPDHSSN Y338
E2A (rat) GKALASIYSPDHSSN Y336
E2A iso2 (rat) GKALASIYSPDHSSN Y336
S341-p
KALASIYsPDHssNN
Upstream
Downstream
1 4
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • MLK2 (human)
Putative in vivo kinases:
  • MLK2 (human)
E2A (human) KALASIYsPDHssNN S341-p
E2A iso2 (human) KALASIYSPDHSSNN S341
E2A (mouse) KALAsIysPDHssNN S339-p
E2A iso2 (mouse) KALASIYSPDHSSNN S339
E2A (rat) KALASIYSPDHSSNN S337
E2A iso2 (rat) KALASIYSPDHSSNN S337
S345-p
SIYsPDHssNNFsss
0 2
E2A (human) SIYsPDHssNNFsss S345-p
E2A iso2 (human) SIYSPDHSSNNFSSs S345
E2A (mouse) sIysPDHssNNFsPs S343-p
E2A iso2 (mouse) SIYSPDHSSNNFSPS S343
E2A (rat) SIYSPDHSSNNFSPS S341
E2A iso2 (rat) SIYSPDHSSNNFSPS S341
S346-p
IYsPDHssNNFsssP
0 6
E2A (human) IYsPDHssNNFsssP S346-p
E2A iso2 (human) IYSPDHSSNNFSSsP S346
E2A (mouse) IysPDHssNNFsPsP S344-p
E2A iso2 (mouse) IYSPDHSSNNFSPSP S344
E2A (rat) IYSPDHSSNNFSPSP S342
E2A iso2 (rat) IYSPDHSSNNFSPSP S342
S350-p
DHssNNFsssPstPV
0 6
E2A (human) DHssNNFsssPstPV S350-p
E2A iso2 (human) DHSSNNFSSsPStPV S350
E2A (mouse) DHssNNFsPsPstPV S348-p
E2A iso2 (mouse) DHSSNNFSPSPSTPV S348
E2A (rat) DHSSNNFSPSPSTPV S346
E2A iso2 (rat) DHSSNNFSPSPSTPV S346
S351-p
HssNNFsssPstPVG
0 8
E2A (human) HssNNFsssPstPVG S351-p
E2A iso2 (human) HSSNNFSSsPStPVG S351
E2A (mouse) HssNNFsPsPstPVG P349
E2A iso2 (mouse) HSSNNFSPSPSTPVG P349
E2A (rat) HSSNNFSPSPSTPVG P347
E2A iso2 (rat) HSSNNFSPSPSTPVG P347
S352-p
ssNNFsssPstPVGs
Upstream
Downstream
2 4
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • MLK2 (human)
Putative in vivo kinases:
  • MLK2 (human)
E2A (human) ssNNFsssPstPVGs S352-p
E2A iso2 (human) SSNNFSSsPStPVGs S352-p
E2A (mouse) ssNNFsPsPstPVGs S350-p
E2A iso2 (mouse) SSNNFSPSPSTPVGS S350
E2A (rat) SSNNFSPSPSTPVGS S348
E2A iso2 (rat) SSNNFSPSPSTPVGS S348
S354-p
NNFsssPstPVGsPQ
0 11
E2A (human) NNFsssPstPVGsPQ S354-p
E2A iso2 (human) NNFSSsPStPVGsPQ S354
E2A (mouse) NNFsPsPstPVGsPQ S352-p
E2A iso2 (mouse) NNFSPSPSTPVGSPQ S352
E2A (rat) NNFSPSPSTPVGSPQ S350
E2A iso2 (rat) NNFSPSPSTPVGSPQ S350
T355-p
NFsssPstPVGsPQG
Upstream
Downstream
3 25
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • MLK2 (human)
Putative in vivo kinases:
  • MLK2 (human)
E2A (human) NFsssPstPVGsPQG T355-p
E2A iso2 (human) NFSSsPStPVGsPQG T355-p
E2A (mouse) NFsPsPstPVGsPQG T353-p
E2A iso2 (mouse) NFSPSPSTPVGSPQG T353
E2A (rat) NFSPSPSTPVGSPQG T351
E2A iso2 (rat) NFSPSPSTPVGSPQG T351
S359-p
sPstPVGsPQGLAGt
Upstream
Downstream
2 33
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • MLK2 (human)
Putative in vivo kinases:
  • MLK2 (human)
E2A (human) sPstPVGsPQGLAGt S359-p
E2A iso2 (human) sPStPVGsPQGLAGT S359-p
E2A (mouse) sPstPVGsPQGLPGt S357-p
E2A iso2 (mouse) SPSTPVGSPQGLPGT S357
E2A (rat) SPSTPVGSPQGLPGT S355
E2A iso2 (rat) SPSTPVGSPQGLPGT S355
T366-p
sPQGLAGtsQWPrAG
0 5
E2A (human) sPQGLAGtsQWPrAG T366-p
E2A iso2 (human) sPQGLAGTSQWPRAG T366
E2A (mouse) sPQGLPGtsQWPrAG T364-p
E2A iso2 (mouse) SPQGLPGTSQWPRAG T364
E2A (rat) SPQGLPGTSQWPRAG T362
E2A iso2 (rat) SPQGLPGTSQWPRAG T362
S367-p
PQGLAGtsQWPrAGA
0 2
E2A (human) PQGLAGtsQWPrAGA S367-p
E2A iso2 (human) PQGLAGTSQWPRAGA S367
E2A (mouse) PQGLPGtsQWPrAGA S365-p
E2A iso2 (mouse) PQGLPGTSQWPRAGA S365
E2A (rat) PQGLPGTSQWPRAGA S363
E2A iso2 (rat) PQGLPGTSQWPRAGA S363
R371-m1
AGtsQWPrAGAPGAL
0 12
E2A (human) AGtsQWPrAGAPGAL R371-m1
E2A iso2 (human) AGTSQWPRAGAPGAL R371
E2A (mouse) PGtsQWPrAGAPsAL R369-m1
E2A iso2 (mouse) PGTSQWPRAGAPSAL R369
E2A (rat) PGTSQWPRAGAPSAL R367
E2A iso2 (rat) PGTSQWPRAGAPSAL R367
G376
WPrAGAPGALsPsyD
0 1
E2A (human) WPrAGAPGALsPsyD G376
E2A iso2 (human) WPRAGAPGALSPSYD G376
E2A (mouse) WPrAGAPsALsPNYD S374-p
E2A iso2 (mouse) WPRAGAPSALsPNYD S374
E2A (rat) WPRAGAPSALSPNYD S372
E2A iso2 (rat) WPRAGAPSALSPNYD S372
S379-p
AGAPGALsPsyDGGL
Upstream
Downstream
1 46
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • MLK2 (human)
Putative in vivo kinases:
  • MLK2 (human)
Treatment
  • ischemia
  • metastatic potential
  • nocodazole
E2A (human) AGAPGALsPsyDGGL S379-p
E2A iso2 (human) AGAPGALSPSYDGGL S379
E2A (mouse) AGAPsALsPNYDAGL S377-p
E2A iso2 (mouse) AGAPSALsPNYDAGL S377-p
E2A (rat) AGAPSALSPNYDAGL S375
E2A iso2 (rat) AGAPSALSPNYDAGL S375
S381-p
APGALsPsyDGGLHG
0 4
E2A (human) APGALsPsyDGGLHG S381-p
E2A iso2 (human) APGALSPSYDGGLHG S381
E2A (mouse) APsALsPNYDAGLHG N379
E2A iso2 (mouse) APSALsPNYDAGLHG N379
E2A (rat) APSALSPNYDAGLHG N377
E2A iso2 (rat) APSALSPNYDAGLHG N377
Y382-p
PGALsPsyDGGLHGL
0 2
E2A (human) PGALsPsyDGGLHGL Y382-p
E2A iso2 (human) PGALSPSYDGGLHGL Y382
E2A (mouse) PsALsPNYDAGLHGL Y380
E2A iso2 (mouse) PSALsPNYDAGLHGL Y380
E2A (rat) PSALSPNYDAGLHGL Y378
E2A iso2 (rat) PSALSPNYDAGLHGL Y378
T411-p
LRSHAVGtAGDMHTL
0 1
E2A (human) LRSHAVGtAGDMHTL T411-p
E2A iso2 (human) LRSHAVGTAGDMHTL T411
E2A (mouse) LRSHAVGTASDLHGL T408
E2A iso2 (mouse) LRSHAVGTASDLHGL T408
E2A (rat) LRSHAVGTASELHGL T406
E2A iso2 (rat) LRSHAVGTASELHGL T406
K498-sm
TAAASEIkREEKEDE
0 1
E2A (human) TAAASEIkREEKEDE K498-sm
E2A iso2 (human) TAAASEIKREEKEDE K498
E2A (mouse) TAGASEIKREEKEDE K496
E2A iso2 (mouse) TAGASEIKREEKEDE K496
E2A (rat) TAGASEIKREEKEDE K494
E2A iso2 (rat) TAGASEIKREEKEDE K494
S509-p
KEDEENTsAADHsEE
0 1
E2A (human) KEDEENTsAADHsEE S509-p
E2A iso2 (human) KEDEENTSAADHSEE S509
E2A (mouse) KEDEEIASVADAEED S507
E2A iso2 (mouse) KEDEEIASVADAEED S507
E2A (rat) KEDEEVTSVADAEED S505
E2A iso2 (rat) KEDEEVTSVADAEED S505
S514-p
NTsAADHsEEEKKEL
0 2
E2A (human) NTsAADHsEEEKKEL S514-p
E2A iso2 (human) NTSAADHSEEEKKEL S514
E2A (mouse) EIASVADAEEDKKDL A511
E2A iso2 (mouse) EIASVADAEEDKKDL A511
E2A (rat) EVTSVADAEEDKKDL A509
E2A iso2 (rat) EVTSVADAEEDKKDL A509
A526
KELKAPRARtsPDED
0 3
E2A (human) KELKAPRARtsPDED A526
E2A iso2 (human) KELKAPRARtsstDE A526
E2A (mouse) KDLKVPRTRTSPDED T523
E2A iso2 (mouse) KDLKVPRtRtsstDE T523-p
E2A (rat) KDLKVPRTRTSPDED T521
E2A iso2 (rat) KDLKVPRTRTSsTDE T521
T528-p
LKAPRARtsPDEDED
0 47
E2A (human) LKAPRARtsPDEDED T528-p
E2A iso2 (human) LKAPRARtsstDEVL T528-p
E2A (mouse) LKVPRTRTSPDEDED T525
E2A iso2 (mouse) LKVPRtRtsstDEVL T525-p
E2A (rat) LKVPRTRTSPDEDED T523
E2A iso2 (rat) LKVPRTRTSsTDEVL T523
S529-p
KAPRARtsPDEDEDD
0 35
E2A (human) KAPRARtsPDEDEDD S529-p
E2A iso2 (human) KAPRARtsstDEVLs S529-p
E2A (mouse) KVPRTRTSPDEDEDD S526
E2A iso2 (mouse) KVPRtRtsstDEVLs S526-p
E2A (rat) KVPRTRTSPDEDEDD S524
E2A iso2 (rat) KVPRTRTSsTDEVLS S524
-
gap
1 326
E2A (human) gap -
E2A iso2 (human) APRARtsstDEVLsL S530-p
E2A (mouse) gap -
E2A iso2 (mouse) VPRtRtsstDEVLsL S527-p
E2A (rat) gap -
E2A iso2 (rat) VPRTRTSsTDEVLSL S525-p
-
gap
0 61
E2A (human) gap -
E2A iso2 (human) PRARtsstDEVLsLE T531-p
E2A (mouse) gap -
E2A iso2 (mouse) PRtRtsstDEVLsLE T528-p
E2A (rat) gap -
E2A iso2 (rat) PRTRTSsTDEVLSLE T526
-
gap
0 5
E2A (human) gap -
E2A iso2 (human) sstDEVLsLEEKDLR S536-p
E2A (mouse) gap -
E2A iso2 (mouse) sstDEVLsLEEKDLR S533-p
E2A (rat) gap -
E2A iso2 (rat) SsTDEVLSLEEKDLR S531
K570
RDINEAFKELGRMCQ
0 1
E2A (human) RDINEAFKELGRMCQ K570
E2A iso2 (human) RDINEAFRELGRMCQ R567
E2A (mouse) RDINEAFkELGRMCQ K567-ac
E2A iso2 (mouse) RDINEAFRELGRMCQ R564
E2A (rat) RDINEAFKELGRMCQ K565
E2A iso2 (rat) RDINEAFRELGRMCQ R562
K570-ub
RDINEAFkELGRMCQ
0 4
E2A (human) RDINEAFkELGRMCQ K570-ub
E2A iso2 (human) RDINEAFRELGRMCQ R567
E2A (mouse) RDINEAFKELGRMCQ K567
E2A iso2 (mouse) RDINEAFRELGRMCQ R564
E2A (rat) RDINEAFKELGRMCQ K565
E2A iso2 (rat) RDINEAFRELGRMCQ R562
S582
MCQLHLNSEkPQTKL
0 2
E2A (human) MCQLHLNSEkPQTKL S582
E2A iso2 (human) MCQMHLKsDKAQTKL S579-p
E2A (mouse) MCQLHLSSEKPQTKL S579
E2A iso2 (mouse) MCQLHLKSDKAQTKL S576
E2A (rat) MCQLHLSTEKPQTKL T577
E2A iso2 (rat) MCQLHLKSDKAQTKL S574
K584-ub
QLHLNSEkPQTKLLI
0 1
E2A (human) QLHLNSEkPQTKLLI K584-ub
E2A iso2 (human) QMHLKsDKAQTKLLI K581
E2A (mouse) QLHLSSEKPQTKLLI K581
E2A iso2 (mouse) QLHLKSDKAQTKLLI K578
E2A (rat) QLHLSTEKPQTKLLI K579
E2A iso2 (rat) QLHLKSDKAQTKLLI K576
K614-ub
RERNLNPkAACLKRR
0 5
E2A (human) RERNLNPkAACLKRR K614-ub
E2A iso2 (human) RERNLNPKAACLKRR K611
E2A (mouse) RERNLNPKAACLKRR K611
E2A iso2 (mouse) RERNLNPKAACLKRR K608
E2A (rat) RERNLNPKAACLKRR K609
E2A iso2 (rat) RERNLNPKAACLKRR K606